Interim results of a real-world observational study of eribulin in soft tissue sarcoma including rare subtypes

Although eribulin is used to treat soft tissue sarcomas (STSs), treatment data for rare subtypes are limited. We conducted a post-marketing surveillance study to assess safety and efficacy of eribulin in STS patients stratified by subtype. Japanese patients (n = 256) with advanced or metastatic STS...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Japanese journal of clinical oncology 2019-10, Vol.49 (10), p.938-946
Hauptverfasser: Kobayashi, Eisuke, Naito, Yoichi, Asano, Naofumi, Maejima, Aiko, Endo, Makoto, Takahashi, Shunji, Megumi, Yasunori, Kawai, Akira
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!